News

Caprelsa is indicated to treat symptomatic or progressive medullary thyroid carcinoma in patients with unresectable locally advanced or metastatic disease and is currently available in 28 countries. Currently,

The program is being funded by Global Health Innovative Technology Fund (GHIT), a public interest incorporated association and a fund for promoting the research and development of pharmaceuticals,

The companies entered into an exclusive license in July 2014 to discover, develop and commercialize these products for the treatment of sepsis. Yabao Pharmaceutical R&D president Dr Peng

HepTcell is a peptide-based immunotherapeutic which includes the company’s proprietary Densigen technology. The product candidate includes nine long peptides covering conserved regions of core, polymerase and surface proteins

The initiation of this human trial follows strong pre-clinical results revealing that INO-5150 generated healthy CD8+ T cell responses in animal studies including non-human primates. The company noted

Narcan Nasal Spray has been granted Fast Track Designation by the FDA. Within 60 days of the submission date, the FDA will determine whether it will accept the

Fresenius Kabi Glucagon for Injection is indicated for use as a diagnostic aid during radiologic examinations and is available in 10-packs of 1mg vials. "Glucagon for Injection is

Unlike traditional insulin injections, Insulin PharmFilm, the proprietary nanoformulated transbuccal insulin film product delivers insulin through the use of a rapidly dissolving mucoadhesive film that is placed on

Invion and Hovione will collaborate to develop the proprietary novel technology — a dry powder formulation of the compound INV104 (zafirlukast) delivered by Hovione’s inhaler. Under the terms